Und wieder 1a News bei Calypte!!!!! - 500 Beiträge pro Seite
eröffnet am 01.11.01 09:16:16 von
neuester Beitrag 01.11.01 15:08:13 von
neuester Beitrag 01.11.01 15:08:13 von
Beiträge: 5
ID: 497.588
ID: 497.588
Aufrufe heute: 0
Gesamt: 518
Gesamt: 518
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
gestern 23:15 | 911 | |
gestern 12:15 | 836 | |
20.04.24, 12:11 | 509 | |
gestern 19:30 | 413 | |
vor 1 Stunde | 404 | |
heute 03:00 | 362 | |
heute 05:38 | 343 | |
vor 35 Minuten | 322 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.058,16 | -0,17 | 200 | |||
2. | 2. | 9,5850 | -0,62 | 184 | |||
3. | 3. | 150,34 | -0,80 | 132 | |||
4. | 4. | 0,1900 | -2,06 | 70 | |||
5. | 6. | 0,0211 | -32,59 | 29 | |||
6. | 5. | 6,7380 | -0,09 | 29 | |||
7. | 7. | 1,3500 | -0,74 | 29 | |||
8. | 15. | 2,3180 | -1,61 | 26 |
An alle Caly-Investierten. Es gibt mal wieder gute News! Soweit ich die Message eben überflogen habe, hat Caly`s Distributor Meditech Int. einen Kontrakt mit der CAADPE abgeschlossen, der auch die Lieferung des HIV-1-Antikörper-Urintests beinhaltet. Die Verkaufswelle rollt also an und offensichtlich war es ein ausgezeichneter Schachzug den Verkauf den erfahrenen Leuten von Meditech Int. zu überlassen.
Quelle: http://biz.yahoo.com/bw/011031/310590_1.html
Wednesday October 31, 9:30 pm Eastern Time
Press Release
SOURCE: Calypte Biomedical
Calypte`s HIV-1 Antibody Urine Test Included On CAADPE Purchasing Contract
Calypte`s Distributor, MEDITECH INTERNATIONAL, Awarded Purchasing Contract With CAADPE
ALAMEDA, Calif.--(BW HealthWire)--Oct. 31, 2001--Calypte Biomedical Corp. (OTCBB:CALY - news) announced today that its distributor, MEDITECH INTERNATIONAL, has recently been awarded a group purchasing agreement by the California Association of Alcohol and Drug Program Executives, Inc. (CAADPE) that provides for the inclusion of Calypte`s urine HIV-1 antibody testing products with MEDITECH INTERNATIONAL`s drug and alcohol testing products. Calypte`s urine test will be the only HIV test currently offered by MEDITECH INTERNATIONAL.
CAADPE is an organization comprised of more than 70 member organizations that provide a variety of health services throughout California. While many of these member organizations are focused on drug and alcohol rehabilitation services, many also provide services related to testing and treatment for sexually transmitted diseases (STDs). Testing for HIV, the virus that causes AIDS, is a priority for those CAADPE member organizations that provide public health services for people at high risk for STDs. Many of these members have funding available under Federal and State grants.
``The combination of attractively priced testing for drugs of abuse in urine and Calypte`s urine HIV-1 antibody test provides tremendous added value for the many CAADPE member organizations that can consolidate drug testing and STD testing on one urine sample that can be obtained easily and non-invasively,`` said Jim Saunders, president of MEDITECH INTERNATIONAL. Saunders added, ``We are currently contacting each of the CAADPE member organizations to help each define the specific benefits that they will experience by taking advantage of this contract with CAADPE.``
Nancy Katz, president and CEO of Calypte Biomedical, is pleased with the progress that MEDITECH INTERNATIONAL has made in the time since Calypte announced its decision to contract with MEDITECH INTERNATIONAL as a distributor of Calypte`s products. As Katz indicated, ``The contract awarded to MEDITECH INTERNATIONAL by CAADPE is an excellent indication that MEDITECH INTERNATIONAL understands how to align products to best service customers. We are prepared to work closely with MEDITECH INTERNATIONAL to successfully provide our urine HIV-1 antibody testing products to those CAADPE member organizations that will benefit from the ability to combine many tests in one urine specimen.``
cu biologist
Quelle: http://biz.yahoo.com/bw/011031/310590_1.html
Wednesday October 31, 9:30 pm Eastern Time
Press Release
SOURCE: Calypte Biomedical
Calypte`s HIV-1 Antibody Urine Test Included On CAADPE Purchasing Contract
Calypte`s Distributor, MEDITECH INTERNATIONAL, Awarded Purchasing Contract With CAADPE
ALAMEDA, Calif.--(BW HealthWire)--Oct. 31, 2001--Calypte Biomedical Corp. (OTCBB:CALY - news) announced today that its distributor, MEDITECH INTERNATIONAL, has recently been awarded a group purchasing agreement by the California Association of Alcohol and Drug Program Executives, Inc. (CAADPE) that provides for the inclusion of Calypte`s urine HIV-1 antibody testing products with MEDITECH INTERNATIONAL`s drug and alcohol testing products. Calypte`s urine test will be the only HIV test currently offered by MEDITECH INTERNATIONAL.
CAADPE is an organization comprised of more than 70 member organizations that provide a variety of health services throughout California. While many of these member organizations are focused on drug and alcohol rehabilitation services, many also provide services related to testing and treatment for sexually transmitted diseases (STDs). Testing for HIV, the virus that causes AIDS, is a priority for those CAADPE member organizations that provide public health services for people at high risk for STDs. Many of these members have funding available under Federal and State grants.
``The combination of attractively priced testing for drugs of abuse in urine and Calypte`s urine HIV-1 antibody test provides tremendous added value for the many CAADPE member organizations that can consolidate drug testing and STD testing on one urine sample that can be obtained easily and non-invasively,`` said Jim Saunders, president of MEDITECH INTERNATIONAL. Saunders added, ``We are currently contacting each of the CAADPE member organizations to help each define the specific benefits that they will experience by taking advantage of this contract with CAADPE.``
Nancy Katz, president and CEO of Calypte Biomedical, is pleased with the progress that MEDITECH INTERNATIONAL has made in the time since Calypte announced its decision to contract with MEDITECH INTERNATIONAL as a distributor of Calypte`s products. As Katz indicated, ``The contract awarded to MEDITECH INTERNATIONAL by CAADPE is an excellent indication that MEDITECH INTERNATIONAL understands how to align products to best service customers. We are prepared to work closely with MEDITECH INTERNATIONAL to successfully provide our urine HIV-1 antibody testing products to those CAADPE member organizations that will benefit from the ability to combine many tests in one urine specimen.``
cu biologist
danke für die information. dürfte dieser aktie helfen.
bin nachwievor investiert. hoffe auf eine gute vermarktung.
produkt ist ok.
mfg
bin nachwievor investiert. hoffe auf eine gute vermarktung.
produkt ist ok.
mfg
Hallo zusammen,
die Info wird auch in den Amiboards als sehr positiv bewertet.
Schauen wir mal, was der Kurs heute macht.
@biologist
Warum hast du das nicht direkt unter der Aktie gespeichert ?
Dann gäbe es bestimmt mehr Feedback.
Bis denne
Schmutz
die Info wird auch in den Amiboards als sehr positiv bewertet.
Schauen wir mal, was der Kurs heute macht.
@biologist
Warum hast du das nicht direkt unter der Aktie gespeichert ?
Dann gäbe es bestimmt mehr Feedback.
Bis denne
Schmutz
@Dr. Schmutz
Da hast Du natürlich Recht! Next time I will do so!
cu biologist
Da hast Du natürlich Recht! Next time I will do so!
cu biologist
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
194 | ||
188 | ||
143 | ||
72 | ||
31 | ||
29 | ||
29 | ||
26 | ||
25 | ||
25 |
Wertpapier | Beiträge | |
---|---|---|
25 | ||
23 | ||
23 | ||
23 | ||
23 | ||
21 | ||
20 | ||
20 | ||
20 | ||
20 |